Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Compare 2024 dividend aristocrats ETF fees to find the lowest cost option. This guide highlights expense ratios and what to look for in a low-cost fund.
27,654 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Last week Plug Power stock beat the market by about 7 percent, signaling momentum in hydrogen and clean energy. This ...
Growth stocks cooled in early 2026, but a trio of ETFs offers a resilient path for long-term investors. This piece br...
Gas prices have moved sharply, with a $0.48 jump in one week. This article breaks down the reasons behind the move, w...
Micron stock bounced back after a rough week for semiconductors, fueled by upbeat AI demand chatter and optimism from...
Oil-driven optimism gave broad indices and airlines a lift, but patience and discipline remain essential. Here’s how ...
A pivotal move in AI investing just happened: a memory-focused chip stock joined Nasdaq, giving investors a new way t...
In Q1 2026, Duquesne Family Office quietly expanded its South American equity bets, signaling a macro-led stance that...
Investing in a high-flying name like SpaceX can spark excitement. This article breaks down two strong reasons to wait...
When a rocket-ride valuation grabs headlines, it’s easy to chase the hype. This guide breaks down spacex's market qui...
Delta and United just reported, but the big question remains: what's next airline stocks? This guide breaks down the ...
Traders are chasing the best stocks trade opportunities in a volatile February session. The focus is on highly liquid...